Provided by Tiger Trade Technology Pte. Ltd.

Lyell Immunopharma, Inc.

15.53
+0.18001.17%
Post-market: 15.530.00000.00%19:30 EDT
Volume:104.91K
Turnover:1.63M
Market Cap:380.55M
PE:-1.31
High:16.16
Open:15.54
Low:15.20
Close:15.35
52wk High:45.00
52wk Low:10.50
Shares:24.50M
Float Shares:10.79M
Volume Ratio:0.57
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.8281
EPS(LYR):-16.0562
ROE:-93.28%
ROA:-34.18%
PB:1.63
PE(LYR):-0.97

Loading ...

Bank of America Securities Remains a Sell on Lyell Immunopharma (LYEL)

TIPRANKS
·
Aug 11

Lyell Immunopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Lyell Immunopharma, Inc. Expected to Post a Loss of $2.08 a Share - Earnings Preview

Reuters
·
Aug 08

Analysts’ Top Healthcare Picks: Lyell Immunopharma (LYEL), Janux Therapeutics Inc (JANX)

TIPRANKS
·
Aug 07

Lyell Net Loss Widens to $44.76 Million in Q2 FY26; Revenue Drops to $4,000

Reuters
·
Aug 07

Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million

Reuters
·
Aug 07

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026

GlobeNewswire
·
Aug 07

Lyell Immunopharma, Inc. : Stifel Initiates Coverage with Buy Rating; Target Price $36

THOMSON REUTERS
·
Aug 06

Stifel Initiates Lyell Immunopharma at Buy With $36 Price Target

MT Newswires Live
·
Aug 06

Lyell Immunopharma initiated with a Buy at Stifel

TIPRANKS
·
Aug 06

B. Riley Initiates Lyell Immunopharma at Buy With $44 Price Target

MT Newswires Live
·
Jul 22

Lyell Immunopharma Initiated at Buy by B. Riley Securities

Dow Jones
·
Jul 22

Lyell Immunopharma initiated with a Buy at B. Riley

TIPRANKS
·
Jul 22

Innovative Cellular Therapeutics Holdings Reports Lyell Immunopharma Share Sale Worth $137

Reuters
·
Jul 21

Innovative Cellular Therapeutics Holdings Reports Lyell Immunopharma Common Share Disposal Worth $137.3

Reuters
·
Jul 18

Lyell Immunopharma Files for Secondary Offering of Common Shares

MT Newswires Live
·
Jul 14

Lyell Immunopharma files to sell 1.1M shares of common stock for holders

TIPRANKS
·
Jul 14

Lyell Immunopharma - to Offer up to 1.1 Mln Common Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jul 14

Citizens biotech analyst holds an analyst/industry conference call

TIPRANKS
·
Jul 07

Abcellera Appoints Lyell CEO Lynn Seely to Board as Independent Director

Reuters
·
Jul 06